Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ronald K, Charlton"'
Autor:
Regina Spinnler, Nayera Hamdy, Ingrid Fae, Tamara Vayntrub, Katerina Tarassi, Marcelo Fernandez-Vina, Michael Halagan, Alexandra Tsirogianni, Bernd M. Spriewald, Medhat Askar, Maria Beatriz Rodriguez, Leah Zhrebker, Gideon Hönger, Gottfried Fischer, Karin Padros, Abeer Madbouly, Reem Ameen, Arthur Dunk, Shawna Kennedy, Ronald K. Charlton, Ghada I. Mossallam, Christian Bach, Salem Al Shemmari, Amanda Willis, Kazutoyo Osoegawa
Publikováno v:
Human Immunology. 80:897-905
Since their inception, the International HLA & Immunogenetics Workshops (IHIW) served as a collaborative platform for exchange of specimens, reference materials, experiences and best practices. In this report we present a subset of the results of hum
Autor:
Masafumi Ueno, Salvatore D. Tomasello, Theodore A. Bass, Luis A. Guzman, Murali Kodali, Antonio Tello-Montoliu, Naveen Seecheran, Dominick J. Angiolillo, Bhaloo Desai, Martin M. Zenni, José Luis Ferreiro, Lyndon C. Box, Ronald K. Charlton
Publikováno v:
Journal of the American College of Cardiology. 59(19):1681-1687
Objectives The purpose of this study is to assess the pharmacodynamic effects of different prasugrel dosing regimens in patients on maintenance prasugrel therapy. Background There are a growing number of patients on chronic prasugrel therapy regimens
Autor:
Davide Capodanno, Masafumi Ueno, Antonio Tello-Montoliu, Kodlipet Dharmashankar, Dominick J. Angiolillo, Bhaloo Desai, Salvatore D. Tomasello, Murali Kodali, José Luis Ferreiro, Ronald K. Charlton, Theodore A. Bass, Piera Capranzano
Publikováno v:
JACC: Cardiovascular Interventions. 5(3):293-300
Objectives This study sought to assess the presence of a dose-response effect of cigarette smoking and its impact on high on-treatment platelet reactivity (HPR) in patients with diabetes mellitus treated with clopidogrel. Background Cigarette smoking
Autor:
Davide Capodanno, Sabrina Sumner, Piera Capranzano, Bhaloo Desai, Masafumi Ueno, Kodlipet Dharmashankar, Luis A. Guzman, Lyndon C. Box, Theodore A. Bass, Martin M. Zenni, Ronald K. Charlton, José Luis Ferreiro, Andrew Darlington, Dominick J. Angiolillo
Publikováno v:
Thrombosis and Haemostasis. 106:253-262
SummaryCilostazol is a platelet inhibitor which when added to aspirin and clopidogrel has shown to reduce the risk of recurrent ischaemic events without an increase in bleeding. These clinical benefits have shown to be more pronounced in patients wit
Autor:
Marcelo Fernandez-Vina, Daniel E. Geraghty, Arthur Dunk, Terry Knudsen, Jenifer D. Williams, Medhat Askar, Wyatt C. Nelson, Amanda Willis, Shawna Kennedy, Ronald K. Charlton, Joona Robinson, Kazutoyo Osoegawa
Publikováno v:
Human Immunology. 79:115
Aim Family studies are the gold standard for studying HLA haplotype segregation. This information is critical when studying haplotype associations among populations where few members of the population have been typed, rendering bioinformatics algorit
Autor:
Masafumi Ueno, Theodore A. Bass, Ronald K. Charlton, Dominick J. Angiolillo, Bhaloo Desai, Kodlipet Dharmashankar, José Luis Ferreiro, Davide Capodanno, Andrew Darlington
Publikováno v:
Circulation: Cardiovascular Interventions. 3:436-441
Background— A drug interaction between clopidogrel and omeprazole resulting in impaired platelet inhibition has been reported. It has been suggested that staggering administration of clopidogrel and omeprazole may overcome this pharmacodynamic (PD)
Autor:
Theodore A. Bass, Shinya Goto, Bhaloo Desai, Steven B. Shoemaker, Luis A. Guzman, Mohammed Aslam, Dominick J. Angiolillo, Yoshie Suzuki, Ronald K. Charlton, Lyndon C. Box, Piera Capranzano, Martin M. Zenni
Publikováno v:
European Heart Journal. 29:2202-2211
Aims Patients with type 2 diabetes mellitus (T2DM) have reduced platelet inhibition compared with non-diabetics following P2Y12 receptor blockade. Whether inhibition of P2Y12 signalling can be enhanced by adjunctive treatment with cilostazol in T2DM
Autor:
Ronald K. Charlton, Theodore A. Bass, Marco A. Costa, Luis A. Guzman, Yoshie Suzuki, Bhaloo Desai, Martin M. Zenni, Steven B. Shoemaker, Dominick J. Angiolillo, Esther Bernardo
Publikováno v:
The American Journal of Cardiology. 101:440-445
Updated guidelines on percutaneous coronary intervention recommend increasing the dose of clopidogrel to 150 mg in high-risk patients if50% platelet inhibition is demonstrated. However, to date, the functional impact of this recommendation has been p
Autor:
Bhaloo Desai, Theodore A. Bass, Naveen Seecheran, Davide Capodanno, Masafumi Ueno, Antonio Tello-Montoliu, José Luis Ferreiro, Ronald K. Charlton, Murali Kodali, Salvatore D. Tomasello, Kodlipet Dharmashankar, Rana Alissa, Dominick J. Angiolillo, Piera Capranzano
Publikováno v:
Thrombosis and Haemostasis. 105:730-732
Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease
Autor:
Antonio, Tello-Montoliu, Salvatore D, Tomasello, José Luis, Ferreiro, Masafumi, Ueno, Naveen, Seecheran, Bhaloo, Desai, Murali, Kodali, Ronald K, Charlton, Lyndon C, Box, Martin M, Zenni, Luis A, Guzman, Theodore A, Bass, Dominick J, Angiolillo
Publikováno v:
Journal of the American College of Cardiology. 59(19)
The purpose of this study is to assess the pharmacodynamic effects of different prasugrel dosing regimens in patients on maintenance prasugrel therapy.There are a growing number of patients on chronic prasugrel therapy regimens, leading to questions